These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
199 related items for PubMed ID: 26433558
1. A 46-Year-Old Asian Woman With Liver Mass. Morris GJ, Covey AM, D'Angelica M, Chang DT, Yen Y, Kelley RK, Greenberg H, Tsioulias G. Semin Oncol; 2015 Oct; 42(5):e67-76. PubMed ID: 26433558 [No Abstract] [Full Text] [Related]
2. Synchronous occurrence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in both lobes of the liver. Topaloğlu S, Sağlam K, Çalık A, Cobanoğlu Ü, Öztürk MH. Turk J Gastroenterol; 2014 Apr; 25(2):209-11. PubMed ID: 25003684 [Abstract] [Full Text] [Related]
3. Neoplasms of the liver and the bile ducts. Choi H, Loyer EM, Charnsangavej C. Semin Roentgenol; 2004 Jul; 39(3):412-27. PubMed ID: 15372754 [No Abstract] [Full Text] [Related]
4. Synchronous cancers of gallbladder carcinoma and combined hepatocellular cholangiocarcinoma: an unusual case and literature review. Zhang ZG, Chen Y, Ji R, Zhao YJ, Wang J, Robinson L, Chen XP, Zhang L. BMC Cancer; 2018 Oct 29; 18(1):1046. PubMed ID: 30373546 [Abstract] [Full Text] [Related]
8. [Synchronous double primary hepatic cancer: hepatocellular carcinoma and intrahepatic cholangiocarcinoma]. Kim JO, Jun DW, Jang K. Korean J Gastroenterol; 2013 Aug 25; 62(2):135-9. PubMed ID: 24133714 [No Abstract] [Full Text] [Related]
9. [Combined hepatocellular and cholangiocarcinoma]. Omagari K, Makiyama K, Ikuno N. Ryoikibetsu Shokogun Shirizu; 1995 Aug 25; (7):473-5. PubMed ID: 8749529 [No Abstract] [Full Text] [Related]
10. Hepatobiliary cancers, version 2.2014. Benson AB, D'Angelica MI, Abrams TA, Are C, Bloomston PM, Chang DT, Clary BM, Covey AM, Ensminger WD, Iyer R, Kelley RK, Linehan D, Malafa MP, Meranze SG, Park JO, Pawlik T, Posey JA, Scaife C, Schefter T, Sigurdson ER, Tian GG, Vauthey JN, Venook AP, Yen Y, Zhu AX, Hoffmann KG, McMillian NR, Sundar H. J Natl Compr Canc Netw; 2014 Aug 25; 12(8):1152-82. PubMed ID: 25099447 [Abstract] [Full Text] [Related]
11. Immune Profiling of Combined Hepatocellular- Cholangiocarcinoma Reveals Distinct Subtypes and Activation of Gene Signatures Predictive of Response to Immunotherapy. Nguyen CT, Caruso S, Maille P, Beaufrère A, Augustin J, Favre L, Pujals A, Boulagnon-Rombi C, Rhaiem R, Amaddeo G, di Tommaso L, Luciani A, Regnault H, Brustia R, Scatton O, Charlotte F, Brochériou I, Sommacale D, Soussan P, Leroy V, Laurent A, Le VK, Ta VT, Trinh HS, Tran TL, Gentien D, Rapinat A, Nault JC, Allaire M, Mulé S, Zucman-Rossi J, Pawlotsky JM, Tournigand C, Lafdil F, Paradis V, Calderaro J. Clin Cancer Res; 2022 Feb 01; 28(3):540-551. PubMed ID: 34785581 [Abstract] [Full Text] [Related]
12. A Review on the Update of Combined Hepatocellular Cholangiocarcinoma. Komuta M, Yeh MM. Semin Liver Dis; 2020 May 01; 40(2):124-130. PubMed ID: 31887773 [Abstract] [Full Text] [Related]
13. Rapid progression of combined hepatocellular carcinoma and cholangiocarcinoma. Saboo SS, Krajewski KM, Jagannathan JP, O'Regan KN, Odze R, Ramaiya N, Wolpin BM. Cancer Imaging; 2011 Mar 31; 11(1):37-41. PubMed ID: 21507775 [Abstract] [Full Text] [Related]
14. [Primary sclerosing cholangitis]. Boonstra K, Ponsioen CI, Rauws EA, Beuers U. Ned Tijdschr Geneeskd; 2010 Mar 31; 154():A1476. PubMed ID: 20619015 [Abstract] [Full Text] [Related]
15. Combined hepatocellular and cholangiocarcinoma: clinical features and prognostic study in a Thai population. Chantajitr S, Wilasrusmee C, Lertsitichai P, Phromsopha N. J Hepatobiliary Pancreat Surg; 2006 Mar 31; 13(6):537-42. PubMed ID: 17139428 [Abstract] [Full Text] [Related]
16. Biliary tract cancer. Curley SA. Cancer Treat Res; 1997 Mar 31; 90():273-307. PubMed ID: 9367089 [No Abstract] [Full Text] [Related]
17. [A 42-month disease free survival case of combined hepatocellular-cholangiocarcinoma with lymph node metastases treated with multimodal therapy]. Hayashi H, Beppu T, Ishiko T, Mizumoto T, Masuda T, Okabe K, Baba Y, Okabe H, Takamori H, Kanemitsu K, Hiroto M, Baba H. Gan To Kagaku Ryoho; 2006 Nov 31; 33(12):1941-3. PubMed ID: 17212153 [Abstract] [Full Text] [Related]
18. Modification and implementation of NCCN guidelines on hepatobiliary cancers in the Middle East and North Africa region. Yusuf MA, Kapoor VK, Kamel RR, Kazmi A, Uddin N, Masood N, Al-Abdulkareem A, MENA Hepatobiliary Cancer Regional Guidelines Committee. J Natl Compr Canc Netw; 2010 Jul 31; 8 Suppl 3():S36-40. PubMed ID: 20697130 [Abstract] [Full Text] [Related]
19. Mixed hepatocellular carcinoma and cholangiocarcinoma treated by extended left hepatic lobectomy with resection of the right hepatic vein and preservation of the inferior right hepatic vein after hepatic arterial infusion chemotherapy. Hanazaki K, Fujimori Y, Kajikawa S, Nakata S, Shimozawa N, Adachi W, Amano J. Hepatogastroenterology; 1998 Jul 31; 45(21):812-5. PubMed ID: 9684139 [Abstract] [Full Text] [Related]
20. Treatment Options in Patients Awaiting Liver Transplantation with Hepatocellular Carcinoma and Cholangiocarcinoma. Unzueta A, Cabrera R. Clin Liver Dis; 2017 May 31; 21(2):231-251. PubMed ID: 28364811 [Abstract] [Full Text] [Related] Page: [Next] [New Search]